排序方式： 共有17条查询结果，搜索用时 15 毫秒
1.
运用高分辨率熔解曲线技术检测痛风患者SLC22A12基因intron5(+4668C/T)多态性 总被引：1，自引：0，他引：1
Objective To investigate a new single nucleotid polymorphism (SNP) intron5(+4668C/T) in SLC22A12 in primary gout patients and the association between clinical characteristics and genotypes. Methods One hundred and one primary gout patients and 186 healthy subjects were recruited into this study. Blood pressure, body mass index (BMI) was recorded. Serum uric acid, glucose, lipid and creatinine were detected. DNA was extracted from peripheral blood to amplify the fragment located in intron 5. The genotypes of SLC22A12 can be detected with high-resolution melting (HRM) assay, followed by sequencing analysis. Chi-square test was used for statistical analysis. Results ① A new SNP in intron 5 of SLC22A12 was identi-fied successfully by HRM, which was defined as intron 5 (+4668C/T). CC, CT and TT genotypes were unam-biguously distinguished with HRM technology, which was fully concordant with sequencing. ②The genotypes of CC, CT and TT in male and female groups were 28.1%, 33.7%, 38.2% and 20.0%, 47.1%, 32.9%, respectively.③ However, no significant differences of genotype distribution were found concerning BMI, blood pressure, creatinine, total cholesterol and triglyceride in both male group and female group. But the serum uric acid levels in the CC genotype were significantly higher than those with the CT+TT genotypes. ④ The genotype frequencies of CC and CT+TT in high uric acid group were remarkably different from those in low uric acid group (21.2%, 78.8%,; 35.0%, 65.0%; P<0.05). Conclusion A new SNP has been successfully discovered with HRM technology with simplicity, rapidity and accuracy. T allele of intron 5 (+4668C/T) may be a genetic protective factor for hyperuricemia among Chinese population. 相似文献
2.
目的探讨肝癌缺失基因1(deleted in liver cancer-1,DLC-1)启动子在视网膜母细胞瘤(retinoblastoma,RB)中的甲基化情况及与临床参数的关系。方法收集37例RB石蜡切片,4例正常眼部组织标本和2株RB细胞系(WERI-Rb1及Y79)。用甲基化敏感性高分辨率熔解(MS-HRM)法定量检测DLC-1甲基化情况,用亚硫酸氢盐测序对其进行验证,并用RT-PCR检测WERI-Rb1和Y79细胞系中DLC-1 mRNA的表达。结果 35.1%的RB中存在DLC-1启动子甲基化,而在正常眼部组织中未发现甲基化;WERI-Rb1和Y79检测出DLC-1 mRNA表达。DLC-1启动子甲基化与肿瘤分化、伴随其他肿瘤和家族史均无显著关系,但单侧RB患者中的DLC-1甲基化率明显高于双侧患者(P<0.05)。结论 RB患者DLC-1启动子存在一定程度的甲基化,DLC-1甲基化在RB的发生、发展中具有一定的作用。 相似文献
3.
4.
5.
6.
7.
8.
9.
目的 SLC2A9是新近发现的尿酸转运子,该基因单核苷酸多态性可影响血清尿酸水平。本研究检测SLC2A9基因第6内含子rs7442295多态性在中国男性痛风和原发性高尿酸血症患者中的分布情况以及与尿酸代谢指标的相关性。方法 选取268例原发性痛风患者和288名健康志愿者,分别检测血压、体质量指数、血尿酸、血糖、血脂、肾功能水平,并同时提取外周血DNA,运用高分辨率熔解曲线(HRM)分析rs7442295基因型,并用测序法证实。统计学方法采用x2检验及t检验。结果 运用HRM技术能准确区分rs7442295 A/A和A/G基因型,而G/G基因型则在本研究人群中未发现。A/A和A/G基因型在人群分布频率分别是96.2％和3.8％。与健康对照组相比,痛风组的A/A和A/G基因型频率及A、G等位基因频率分布差异无统计学意义(x2=0.003,P=0.82; x2=0.003,P=1.00),但携带A/G基因型个体的尿酸水平[(293±100) μmol/L]明显低于携带A/A基因型的个体[(392±133) μmol/L]（t=2.426,P＜0.01）,且正常尿酸组内A/G基因型频率明显高于高尿酸组(x2=6.279,P=0.01）,基于HRM技术的基因分型结果与测序法所得结果完全一致。结论 SLC2A9基因rs7442295多态性可能是评估中国汉族男性人群原发性高尿酸血症危险性的一个遗传学标志,HRM技术简单、方便、快速,并实现闭管检测,非常适合单核苷酸多态性分析。 相似文献
10.
Objective To investigate a new single nucleotid polymorphism (SNP) intron5(+4668C/T) in SLC22A12 in primary gout patients and the association between clinical characteristics and genotypes. Methods One hundred and one primary gout patients and 186 healthy subjects were recruited into this study. Blood pressure, body mass index (BMI) was recorded. Serum uric acid, glucose, lipid and creatinine were detected. DNA was extracted from peripheral blood to amplify the fragment located in intron 5. The genotypes of SLC22A12 can be detected with high-resolution melting (HRM) assay, followed by sequencing analysis. Chi-square test was used for statistical analysis. Results ① A new SNP in intron 5 of SLC22A12 was identi-fied successfully by HRM, which was defined as intron 5 (+4668C/T). CC, CT and TT genotypes were unam-biguously distinguished with HRM technology, which was fully concordant with sequencing. ②The genotypes of CC, CT and TT in male and female groups were 28.1%, 33.7%, 38.2% and 20.0%, 47.1%, 32.9%, respectively.③ However, no significant differences of genotype distribution were found concerning BMI, blood pressure, creatinine, total cholesterol and triglyceride in both male group and female group. But the serum uric acid levels in the CC genotype were significantly higher than those with the CT+TT genotypes. ④ The genotype frequencies of CC and CT+TT in high uric acid group were remarkably different from those in low uric acid group (21.2%, 78.8%,; 35.0%, 65.0%; P<0.05). Conclusion A new SNP has been successfully discovered with HRM technology with simplicity, rapidity and accuracy. T allele of intron 5 (+4668C/T) may be a genetic protective factor for hyperuricemia among Chinese population. 相似文献